The arrival of teprotumumab has been hailed as a game-changer in the treatment thyroid eye disease (TED).1Patel A. Yang H. Douglas R.S. A new era disease.Am J Ophthalmol. 2019; 208: 281-288Abstract Full Text PDF PubMed Scopus (18) Google Scholar This monoclonal antibody to insulin-like growth factor-1 receptor is first Food and Drug Administration (FDA)-approved for TED.2Food Administration. FD...